Advertisement

Mycoplasma genitalium, a stealth female reproductive tract

  • Newton Sergio De CarvalhoEmail author
  • Gabriele Palú
  • Steven S. Witkin
Review
  • 44 Downloads

Abstract

Mycoplasma genitalium was first isolated from the urethral swabs of two symptomatic men with urethritis in 1980. It is a sexually transmitted bacterium associated with a number of urogenital conditions in women like cervicitis, endometritis, pelvic inflammatory disease, infertility, and susceptibility to human immunodeficiency virus (HIV). However, M. genitalium may also act like a stealth pathogen at female reproductive tract, giving no symptoms. Its prevalence varies between different groups, with the average being 0.5–10% in the general population and 20–40% in women with sexually transmitted infections. The recommended treatment of this infection is azithromycin as a single 1-g dose. However, in recent years, macrolide resistance has increased which is significantly lowering the cure rate, being less than 50% in some studies. New treatment regimens need to be investigated due to increasing drug resistance. The discussion and suggestion of an algorithm for management of this infection is the highlight of this paper.

Keywords

Mycoplasma genitalium Sexually transmitted infection Resistance Prevalence Treatment 

Notes

Author contribution

Newton Sergio de Carvalho: Manuscript writing, data collection.

Gabriele Palú: Manuscript writing.

Steven S. Witkin: Data management, manuscript editing.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    McGowin CL, Totten PA (2017) The unique microbiology and molecular pathogenesis of Mycoplasma genitalium. J Infect Dis 216(suppl_2):S382–S388CrossRefGoogle Scholar
  2. 2.
    Suthers PF, Dasika MS, Kumar VS, Denisov G, Glass JI, Maranas CD (2009) Genome-scale metabolic reconstruction of mycoplasma genitalium, iPS189. PLoS Comput Biol 5(2):e1000285CrossRefGoogle Scholar
  3. 3.
    Dehon PM, McGowin CL Mycoplasma genitalium infection is associated with microscopic signs of cervical inflammation in liquid cytology specimens. J Clin Microbiol 52(7):2398–2405 [s.l.], 23 abr. 2014. American Society for MicrobiologyGoogle Scholar
  4. 4.
    Gaydos CA (2017) Mycoplasma genitalium: accurate diagnosis is necessary for adequate treatment. J Infect Dis 216(suppl_2):S406–S411CrossRefGoogle Scholar
  5. 5.
    Fookes MC, Hadfield J, Harris S, Parmar S, Unemo M, Jensen JS, Thomson NR (2017) Mycoplasma genitalium: whole genome sequence analysis, recombination and population structure. BMC Genomics 18:1.  https://doi.org/10.1186/s12864-017-4399-6 CrossRefGoogle Scholar
  6. 6.
    Gibson DG, Benders GA, Andrews-Pfannkoch C et al (2008) Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science 319:1215–1220CrossRefGoogle Scholar
  7. 7.
    Patel KK, Salva PS, Webley WC (2011) Colonization of paediatric lower respiratory tract with genital Mycoplasma species. Respirology 16(7):1081–1087 [s.l.], 26 set. WileyCrossRefGoogle Scholar
  8. 8.
    Taylor-Robinson D, Jensen JS (2011) Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev, p. 498–514Google Scholar
  9. 9.
    Manhart L, Holmes K, Hughes JP, Houston L, Totten PA (2007) Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health 97:1118–1125CrossRefGoogle Scholar
  10. 10.
    McGowin CL, Anderson-Smits C (2011) Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog 7(5):e1001324CrossRefGoogle Scholar
  11. 11.
    Sonnenberg P, Ison CA, Clifton S et al (2015) Epidemiology of Mycoplasma genitalium in British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Int J Epidemiol 44(6):1982–1994CrossRefGoogle Scholar
  12. 12.
    Hamasuna R, Imai H (2008) Prevalence of mycoplasma genitalium among female students in vocational schools in Japan. Sex Transm Infect 84(4):303–305CrossRefGoogle Scholar
  13. 13.
    Lokken EM, Balkus JE, Kiarie J et al (2017) Association of recent bacterial vaginosis with acquisition of Mycoplasma genitalium. Am J Epidemiol 186(2):194–201CrossRefGoogle Scholar
  14. 14.
    Campos et al (2015) Prevalence of Mycoplasma genitalium and Mycoplasma hominis in urogenital tract of Brazilian women. BMC Infect Dis 15:60CrossRefGoogle Scholar
  15. 15.
    Rodrigues MM, Fernandes PÁ, Haddad JP (2011) Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples. J Obstet Gynaecol 31(3):237–2241CrossRefGoogle Scholar
  16. 16.
    Baumann L, Cina M, Egli-Gany D et al (2018) Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect 94(4):255–262CrossRefGoogle Scholar
  17. 17.
    Manhart LE, Critchlow CW, Holmes KK, Dutro SM et al (2003) Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 187(4):650–657CrossRefGoogle Scholar
  18. 18.
    Oakeshott P, Aghaizu A, Hay P et al (2010) Is Mycoplasma genitalium in women the new chlamydia? A community-based prospective cohort study. Clin Infect Dis 51(10):1160–1166CrossRefGoogle Scholar
  19. 19.
    Daley G et al (2014) Mycoplasma genitalium: a review. Int J STD AIDS 25(7):475–487 [s.l.], 11 fev. SAGE PublicationsCrossRefGoogle Scholar
  20. 20.
    Thurman AR et al (2010) Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads. Int J STD AIDS 21:177–183CrossRefGoogle Scholar
  21. 21.
    Ma L et al (2008) Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol 8:130CrossRefGoogle Scholar
  22. 22.
    Sethi S, Singh G, Samanta P, Sharma M (2012) Mycoplasma genitalium: an emerging sexually transmitted pathogen. Indian J Med Res 136(6):942–955Google Scholar
  23. 23.
    Edlund M, Blaxhult A, Bratt G (2012) The spread of Mycoplasma genitalium among men who have sex with men. Int J STD AIDS 23:455–456CrossRefGoogle Scholar
  24. 24.
    Lillis RA, Nsuami MJ, Myers L, Martin DH (2011) Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J Clin Microbiol 49:1990–1992CrossRefGoogle Scholar
  25. 25.
    Jensen JS, Cusini M, Gomberg M, Moi H (2016) 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol 30:1650–1656.  https://doi.org/10.1111/jdv.13849 CrossRefGoogle Scholar
  26. 26.
    Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC (2009) Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 36:598–606CrossRefGoogle Scholar
  27. 27.
    Falk L, Fredlund H, Jensen J (2005) Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 81(1):73–78CrossRefGoogle Scholar
  28. 28.
    Mavedzenge SN, Müller EE, Lewis DA et al (2015) Mycoplasma genitalium is associated with increased genital HIV type 1 RNA in Zimbabwean women. J Infect Dis 211(9):1388–1398CrossRefGoogle Scholar
  29. 29.
    Lawton B, Rose SB, Bromhead C et al (2008) High prevalence of Mycoplasma genitalium in women presenting for termination of pregnancy. Contraception. 77(4):294–298CrossRefGoogle Scholar
  30. 30.
    Cohen CR, Nosek M, Meier A et al (2007) Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis 34(5):274–279Google Scholar
  31. 31.
    Uno M et al (1997) Mycoplasma genitalium in the cervices of Japanese women. Sex Transm Dis 24:284–286CrossRefGoogle Scholar
  32. 32.
    Bjartling C, Osser S, Persson K (2010) The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 117:361–364CrossRefGoogle Scholar
  33. 33.
    Moi H, Reinton N, Moghaddam A (2009) Mycoplasma genitalium in women with lower genital tract inflammation. Sex Transm Infect 85:10–14CrossRefGoogle Scholar
  34. 34.
    Lis R, Rowhani Rahbar A, Manhart LE (2015) Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 6(3):418–426CrossRefGoogle Scholar
  35. 35.
    Cohen CR, Mugo NR, Astete SG et al (2005) Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect 81:463–466CrossRefGoogle Scholar
  36. 36.
    Haggerty CL, Totten PA, Astete SG et al (2008) Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 84:338–342CrossRefGoogle Scholar
  37. 37.
    McGowin CL, Spagnuolo RA, Pyles RB (2010) Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation. Infect Immun 78:726–736CrossRefGoogle Scholar
  38. 38.
    Garcia P et al (2006) Risk of preterm birth associated with Mycoplasma genitalium infection. Am J Obstet Gynecol 195:S53CrossRefGoogle Scholar
  39. 39.
    Kataoka S et al (2006) Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol 44:51–55CrossRefGoogle Scholar
  40. 40.
    Labbe AC et al (2002) Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bissau. Sex Transm Infect 78:289–291CrossRefGoogle Scholar
  41. 41.
    Lu GC et al (2001) Midtrimester vaginal Mycoplasma genitalium in women with subsequent spontaneous preterm birth. Am J Obstet Gynecol 185:163–165CrossRefGoogle Scholar
  42. 42.
    Averbach SH, Hacker MR, Yiu T, Modest AM, Dimitrakoff J, Ricciotti HA (2013) Mycoplasma genitalium and preterm delivery at an urban community health center. Int J Gynaecol Obstet 123:54–57CrossRefGoogle Scholar
  43. 43.
    Short VL et al (2010) Mycoplasma genitalium among young, urban pregnant women. Infect Dis Obstet Gynecol 2010:984760CrossRefGoogle Scholar
  44. 44.
    Edwards RK et al (2006) Assessing the relationship between preterm delivery and various microorganisms recovered from the lower genital tract. J Matern Fetal Neonatal Med 19:357–363CrossRefGoogle Scholar
  45. 45.
    Hitti J et al (2010) Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women. Sex Transm Dis 37:81–85CrossRefGoogle Scholar
  46. 46.
    Svenstrup HF et al (2008) Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility—a prospective study. Fertil Steril 90:513–520CrossRefGoogle Scholar
  47. 47.
    Napierala Mavedzenge S, Weiss HA (2009) Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis. AIDS (London, England) 23(5):611–620CrossRefGoogle Scholar
  48. 48.
    Vandepitte J, Weiss HA, Bukenya J et al (2014) Association between Mycoplasma genitalium infection and HIV acquisition among female sex workers in Uganda: evidence from a nested case-control study. Sex Transm Infect 90:545–549CrossRefGoogle Scholar
  49. 49.
    Manhart LE (2012) Another STI associated with HIV-1 acquisition: now what? AIDS 26:635–637CrossRefGoogle Scholar
  50. 50.
    Tabrizi SN, Su J, Bradshaw CS (2017) Prospective evaluation of ResistancePlus MG, a new multiplex quantitative PCR assay for detection of Mycoplasma genitalium and macrolide resistance. J Clin Microbiol 55(6):1915–1919CrossRefGoogle Scholar
  51. 51.
    Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R (2008) Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 47:1546–1553.  https://doi.org/10.1086/593188 CrossRefGoogle Scholar
  52. 52.
    Tabrizi SN, Tan LY, Walker S, Twin J, Poljak M, Bradshaw CS, Fairley CK, Bissessor M, Mokany E, Todd AV, Garland SM (2016) Multiplex assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance using PlexZyme and PlexPrime technology. PLoS One 11:e0156740.  https://doi.org/10.1371/journal.pone.0156740 CrossRefGoogle Scholar
  53. 53.
    Workowski KA, Bolan GA, Centers for Disease Control and Prevention (2015) Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64:1–137CrossRefGoogle Scholar
  54. 54.
    Jensen JS, Bradshaw C (2015) Management of Mycoplasma genitalium infections - can we hit a moving target? BMC Infect Dis 15:343. Published 2015 Aug 19.  https://doi.org/10.1186/s12879-015-1041-6 CrossRefGoogle Scholar
  55. 55.
    Lau A, Bradshaw CS, Lewis D, Fairley CK, Chen MY, Kong FYS, Hocking JS (2015) The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis 61(9):1389–1399CrossRefGoogle Scholar
  56. 56.
    Bissessor M, Tabrizi SN, Twin J, Abdo H, Fairley CK, Chen MY, Vodstrcil LA, Jensen JS, Hocking JS, Garland SM, Bradshaw CS (2015) Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis 60:1228–1236CrossRefGoogle Scholar
  57. 57.
    Nijhuis RH, Severs TT, Van der Vegt DS, Van Zwet AA, Kusters JG (2015) High levels of macrolide resistance-associated mutations in Mycoplasma genitalium warrant antibiotic susceptibility-guided treatment. J Antimicrob Chemother 70:2515–2518CrossRefGoogle Scholar
  58. 58.
    Kikuchi M, Ito S, Yasuda M et al (2014) Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. J Antimicrob Chemother 69:2376–2382CrossRefGoogle Scholar
  59. 59.
    Salado-Rasmussen K, Jensen JS (2014) Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis 59:24–30CrossRefGoogle Scholar
  60. 60.
    Braam JF, van Dommelen L, Henquet CJM, van de Bovenkamp JHB, Kusters JG (2017) Multidrug-resistant Mycoplasma genitalium infections in Europe. Eur J Clin Microbiol Infect Dis 36(9):1565–1567CrossRefGoogle Scholar
  61. 61.
    Horner P, Blee K, Adams E (2014) Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! Curr Opin Infect Dis 27:68–74CrossRefGoogle Scholar
  62. 62.
    Manhart et al (2011) Mycoplasma genitalium: should we treat and how? Clin Infect Dis 53(S3):S129–S142CrossRefGoogle Scholar
  63. 63.
    Mena LA, Mroczkowski TF, Nsuami M, Martin DH (2009) A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 48:1649–1654CrossRefGoogle Scholar
  64. 64.
    Manhart LE, Gillespie CW, Lowens MS et al (2013) Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis 56:934CrossRefGoogle Scholar
  65. 65.
    FDA Drug Safety Communication: FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together - FDA Drug Safety Communication issued July 26, 2016 - https://www.fda.gov/drugs/drugsafety/ucm500143.htm)
  66. 66.
    Gundevia Z, Foster R, Jamil MS, McNulty A (2015) Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort. Sex Transm Infect 91:11–13CrossRefGoogle Scholar
  67. 67.
    Couldwell DL, Lewis DA (2015) Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations. Infect Drug Resist 8:147–161Google Scholar
  68. 68.
    Bradshaw C, Twin J, Bissessor M et al (2015) 006.1 The efficacy of pristinamycin for mycoplasma genitalium – an increasing multidrug resistant pathogen. Sex Transm Infect 91:A37CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Obstetrics and Gynecology Department of Federal University of Paraná (DTG/UFPR)Gynecology and Obstetrics Infections Sector from Clinical Hospital - UFPRCuritibaBrazil
  2. 2.Division of Immunology and Infectious DiseasesDepartment of Obstetrics and Gynecology, Weill Cornell MedicineNew YorkUSA

Personalised recommendations